1) Review multidisciplinary principles in the evaluation and management of potentially curable non-small cell lung cancers.
2) Understand systemic strategies in treating metastatic non-small cell lung cancers with multiple actionable findings on next generation sequencing.
3) Consider systemic treatment options and sequencing in the evolving field of extensive small cell lung cancer management.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation